DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

GlaxoSmithKline (NYSE: GSK)

45.01 0.05 (0.11%)

REAL-TIME: Last trade at

Extended Hours: $45.12 $0.11 (0.24%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

GSK $45.01 0.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.87
Previous Close $44.96
Daily Range $44.77 - $45.25
52-Week Range $41.25 - $56.73
Market Cap $108.1B
P/E Ratio 15.45
Dividend (Yield) $2.45 (5.9%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 3,095,388
Average Daily Volume 4,705,428
Current FY EPS $2.98

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales

Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

Benzinga's Weekend M&A Chatter

Here's Why This Year's Flu Vaccine Isn't Working

Have you ever wondered why the effectiveness of the flu vaccine is so erratic from one year to the next? Here's the answer.

Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog

3 Health Care Stocks Driving The Sector Higher

Novartis CEO: Supporting Affordable Care Act Supports Insuring Americans

Gilead Sciences Still has More Upside

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

CAR-T Vs ErbB3 Market Opportunity Comparison

Johnson & Johnson Riding High On Ebola Vaccines

See More GSK News...

GSK's Top Competitors

GSK $45.01 (0.11%)
Current stock: GSK
JNJ $102.20 (-1.50%)
Current stock: JNJ
NVS $96.87 (0.03%)
Current stock: NVS
RHHBY $35.35 (1.83%)
Current stock: RHHBY